Activity

The combination of a wandering spleen and gastric volvulus is a rare phenomenon. Both conditions are life-threatening if their treatment is delayed. In this communication, we describe a rare association between mesenteroaxial gastric volvulus and a wandering spleen in a two-year-old child, emphasizing the importance of radiological evaluation for early and correct diagnosis.

Removing hardware is a common step in orthopedic treatments, but it often involves a substantial time commitment and can be intricate. Increased surgical time and potential screw damage may arise from the presence of bone or cement adhering to the screws, thus obstructing their removal. We present in this article a straightforward, economical method involving bone wax to shield screw heads from bone overgrowth or cement, leading to simpler implant removal down the road. A barrier is created by applying bone wax over screw heads, preventing the growth of bone or the attachment of cement to the screw heads.

The infection tetanus originates from the toxin of the bacterium Clostridium tetani. Newborns are typically the most vulnerable, but people with incomplete vaccination series are also at risk, and individuals of any age, notably in developing countries, can be impacted. Even though global initiatives for reducing the impact of this disease have proliferated over the past twenty years, the mortality rates in regions such as South Asia and sub-Saharan Africa remain the highest since the 2015-2019 period. In 2017, the regional immunization coverage rate for diphtheria-tetanus toxoid and pertussis (DTP-3) in Latin America reached 89%, but Costa Rica experienced a reduction in its national immunization schedule coverage during the period of 2019 to 2021. fgfr signals Presented in this case study is a 53-year-old woman from Puntarenas, Costa Rica, exhibiting progressive systemic tetanus, culminating in the onset of status epilepticus. In Costa Rica’s central hospital, a prior assessment of her right upper limb paresthesia, lasting three months, included myoclonus and recent ambulation difficulties, leading to a probable Guillain-Barré syndrome diagnosis. Three generalized tonic-clonic seizures, treated with diazepam and phenytoin, occurred during her hospitalisation. As no positive outcome emerged, she was transferred to our medium-sized private hospital to manage the painful spasms and weakness in her lower limbs. No injuries were apparent from the initial examination. Lower-limb spasms, initially mimicking seizures, prompted the initial use of midazolam and magnesium sulfate, which subsequently transitioned to generalized spasms without consciousness loss for up to 15 minutes, notably accompanied by desaturation, tachycardia, and tachypnea. The differential diagnosis ruled out muscle contractions as a symptom of hypocalcemia, neurosyphilis, and epilepsy. Despite this finding, the magnetic resonance imaging procedure showcased fractures localized to T11, L1, and L2. The presence of spasms, opisthotonos, a history of seizures, and a wound on her hand four months prior led to a tetanus diagnosis. Tetanus toxoid (Td), antimicrobial therapy, and human antitetanic immunoglobulin (HTIG) were among the initial treatment protocols, partially restoring the patient’s condition, yet she remained reliant on infusions. Hospitalized for six weeks, the patient developed status epilepticus. Magnetic resonance imaging demonstrated subacute bi-occipital infarcts resulting from hypoxia during prior seizure events. Through the application of lacosamide therapy, the patient’s condition was reversed, guaranteeing the absence of seizures. For the purpose of stabilizing the patient’s condition, a lumbar osteosynthesis, highly favorable in its effect, was performed. The spasms’ intensity and frequency gradually subsided, making possible the gradual discontinuation of infusions and the transition from intravenous to oral benzodiazepine therapy. The patient’s self-limiting spasms necessitate only lacosamide and oral clonazepam for maintenance therapy. This case study reveals the importance of including tetanus in the differential diagnosis, despite a complete vaccination schedule, especially if there are accompanying spasms, convulsions, or a history of wounds or bites. Careful consideration of this report type is necessary to reconsider the key elements of tetanus prevention, diagnosis, management, and treatment; as well as to improve access to essential medicines, such as HTIG, while aiming to enhance the patient’s prognosis in terms of symptom resolution and associated sequelae.

Tirzepatide, acting as a promising treatment for type 2 diabetes mellitus (T2DM), achieves its efficacy by stimulating glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptors, augmenting the benefits of a healthy diet and exercise. Using once-weekly subcutaneous injections of tirzepatide (5 mg, 10 mg, and 15 mg), the SURPASS 1-5 phase 3 clinical trials measured the dose-dependent efficacy and safety profiles in individuals with type 2 diabetes (T2DM), in both monotherapy and combination treatment regimens. Compared to other diabetic medications, tirzepatide has shown a superior ability to achieve better glycemic control, as reflected by its effect on reducing glycosylated hemoglobin and improving both fasting and postprandial glucose. The studies, in addition, display a decrease in body mass, between 62 and 129 kilograms, accompanied by improvements in cardiovascular health brought about by alterations to the lipid profile, lowered blood pressure, and reduced visceral fat. Tirzepatide exhibits a positive safety record, featuring tolerable side effects and a minimal likelihood of causing hypoglycemic events. In the SURPASS 4 clinical trial, people with type 2 diabetes and elevated cardiovascular risk achieved favorable cardiovascular outcomes. In addition, the encouraging results from the SURMOUNT trials and the progress of the SURPASS-CVOT studies will bring a greater clarity on cardiovascular safety in the coming times. Summarizing clinical trials and their outcomes concerning tirzepatide, we investigate its potential future roles in the treatment of obesity, heart failure, and nonalcoholic steatohepatitis.

An aggressive and potentially fatal condition, hemophagocytic lymphohistiocytosis (HLH), results from excessive immune system stimulation. Severe and uncontrolled inflammatory reactions, resulting in the excessive production of immune cells and cytokines, are common in all age groups and many underlying conditions. Failure to detect and properly treat this condition early can result in multiple organ damage, leading to a mortality rate exceeding 55%. The following case details a 38-year-old male patient, who suffered from hemophagocytic lymphohistiocytosis (HLH) concurrently with HIV/AIDS and Epstein-Barr virus (EBV)-related Hodgkin lymphoma. The importance of recognizing HLH and cancer as potential co-morbidities in HIV/AIDS patients is paramount.

The initiation of a medication predisposed to causing drug-induced lupus (DIL) is often accompanied by the development of DIL. Rare though unusual presentations of the condition might be, our patient’s initial signs and symptoms pointed directly to pericarditis. Upon receiving that treatment, he underwent a progressive decline, presenting symptoms of angioedema and a deteriorating cardiopulmonary state. During the patient’s first admission, chest pain was observed, worsening when lying down and improving when sitting upright. A mild pericardial effusion was noted on CT angiography, coupled with widespread ST elevation on the electrocardiogram, both consistent with pericarditis, resulting in the patient’s discharge with colchicine. The patient was readmitted twenty-four hours later, presenting with swelling of the neck and tongue. Autoantibody testing, following a re-evaluation of the patient, demonstrated a positive antinuclear antibody (ANA), implying a probable diagnosis of lupus, possibly related to hydralazine. This report details a rare instance of drug-induced lupus, characterized by an initial presentation of pericarditis that later evolved into worsening angioedema, a phenomenon not previously noted in the literature. Pericarditis and angioedema can serve as the initial indicators of drug-induced lupus in a patient. Both anti-nuclear antibodies, displaying high sensitivity, and anti-histone antibodies, demonstrating high specificity, play pivotal roles in diagnosing drug-induced lupus. For patients, the life-saving aspect lies in early diagnosis and discontinuation of the offending agent at the right moment.

At 34 weeks gestational age, a male neonate was born as a result of spontaneous labor, complicated by fetal distress and meconium-stained amniotic fluid. The newborn infant’s presentation included septic shock and congenital pneumonia immediately after delivery, and subsequent neurological symptoms arose. Blood samples tested positive for Listeria monocytogenes, whereas urine and cerebrospinal fluid cultures were negative. In order to address the neonate’s needs, assisted ventilation for ten days and high-dose, long-term antibiotics were administered. Despite the mother’s categorical denial of an infectious risk of listeriosis, mild respiratory symptoms developed. Her investigation into microbiological components, though excluding placental tissue, was still negative. Vertical transmission was hypothesized but not conclusively established in this case. The infant, asymptomatic upon discharge at 26 days old, has exhibited typical developmental progress up to the current age of eight months. A relatively rare, yet classic, causative agent of neonatal sepsis and meningitis is Listeria monocytogenes. Clinical success in managing this case, absent any epidemiological connection, demonstrates the intricate hurdles in addressing public health outbreaks. Successful treatment of neonatal listeriosis hinges upon seamless communication between the Neonatology and Obstetrics departments, as well as engagement with public health authorities, and a prolonged period of meticulous long-term follow-up is paramount to identify any possible neurological sequelae.